These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 21544804)

  • 21. Circulating enterolactone and risk of breast cancer: a prospective study in New York.
    Zeleniuch-Jacquotte A; Adlercreutz H; Shore RE; Koenig KL; Kato I; Arslan AA; Toniolo P
    Br J Cancer; 2004 Jul; 91(1):99-105. PubMed ID: 15226762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.
    Barnes BB; Steindorf K; Hein R; Flesch-Janys D; Chang-Claude J
    Cancer Epidemiol; 2011 Aug; 35(4):345-52. PubMed ID: 21159569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
    Stuedal A; Gram IT; Bremnes Y; Adlercreutz H; Veierød MB; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2154-9. PubMed ID: 16172225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R; Chang-Claude J; Linseisen J
    Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P; Rubagotti A; Boccardo F
    Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women.
    Anderson LN; Cotterchio M; Boucher BA; Kreiger N
    Int J Cancer; 2013 Apr; 132(7):1683-92. PubMed ID: 22907507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.
    Sherman ME; Rimm DL; Yang XR; Chatterjee N; Brinton LA; Lissowska J; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Cartun R; Mandich D; Rymkiewicz G; Ligaj M; Lukaszek S; Kordek R; Kalaylioglu Z; Harigopal M; Charrette L; Falk RT; Richesson D; Anderson WF; Hewitt SM; García-Closas M
    Int J Cancer; 2007 Sep; 121(5):1079-85. PubMed ID: 17487843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
    Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
    Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating enterolactone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A; Lundin E; Micheli A; Koenig KL; Lenner P; Muti P; Shore RE; Johansson I; Krogh V; Lukanova A; Stattin P; Afanasyeva Y; Rinaldi S; Arslan AA; Kaaks R; Berrino F; Hallmans G; Toniolo P; Adlercreutz H
    Int J Cancer; 2006 Nov; 119(10):2376-81. PubMed ID: 16929490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
    Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
    Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
    Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
    Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
    Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort.
    Shackshaft L; Van Hemelrijck M; Garmo H; Malmström H; Lambe M; Hammar N; Walldius G; Jungner I; Wulaningsih W
    Breast Cancer Res; 2017 Mar; 19(1):22. PubMed ID: 28264697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
    Chen X; Yuan Y; Gu Z; Shen K
    Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk.
    Pedersen GS; Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
    Breast Cancer Res Treat; 2010 Jul; 122(1):199-210. PubMed ID: 19949857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.